How to cite item

Turn on the TORCH before treat your patients: a lesson from a first line study in advanced NSCLC

   
@article{TLCR525,
	author = {Fausto Petrelli and Sandro Barni},
	title = {Turn on the TORCH before treat your patients: a lesson from a first line study in advanced NSCLC},
	journal = {Translational Lung Cancer Research},
	volume = {1},
	number = {3},
	year = {2012},
	keywords = {},
	abstract = {The first line treatment of (EGFR unselected) stage IV non small cell lung cancer (NSCLC), in Western countries, is driven by the disease (histology) and by the patient [age and performance status (PS)]. Infact non-squamous NSCLC benefits more of pemetrexed based-chemotherapy and older or poor PS are prescribed more often monochemotherapy rather than platinum-based doublet. On the contrary, in patients with known, positive, EGFR mutations status, the first line choice is an anti-EGFR tyrosine kinase inhibitor (TKI) as erlotinib or gefitinib according also to data of EURTACH study (1).},
	issn = {2226-4477},	url = {https://tlcr.amegroups.org/article/view/525}
}